Sodium Hypochlorite is a compound of defined chemical structure and pharmaceutical significance whose toxicological characterisation supports health-based exposure limit derivation for pharmaceutical manufacturing occupational safety and cross-contamination control. The relationship between molecular structure and biological potency—assessed through structure-activity relationship analysis and experimental pharmacological and toxicological data—determines the OEB classification and the engineering containment requirements governing manufacturing operations involving Sodium Hypochlorite.
The critical toxicological endpoint driving the PDE for Sodium Hypochlorite is selected through systematic comparison of all available study NOAELs across endpoint categories: general systemic toxicity, neurotoxicity, reproductive and developmental toxicity, genotoxicity, and carcinogenicity.
